Wilson disease

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

10 events
Jun 2026Endocrine Dysfunction in Pediatric Wilson's Disease

Assiut University

TrialNOT YET RECRUITING
May 2026Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.

Orphalan — PHASE3

TrialNOT YET RECRUITING
Feb 2026Description of Renal Involvement in Wilson's Disease

Fondation Ophtalmologique Adolphe de Rothschild

TrialNOT YET RECRUITING
Jan 2026Off Treatment Urinary Copper Excretion in Wilson Disease, Pilot Study

Yale University — NA

TrialRECRUITING
Dec 2025A Clinical Study on the Treatment of Wilson Disease With ATP7B mRNA/LNP (DSL101)

DSciLab Co., Ltd. — EARLY_PHASE1

TrialRECRUITING
Dec 2025Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial

Prime Medicine, Inc.

TrialRECRUITING
Dec 2025Multifaceted Assessment of Patients With Wilson's Disease in a Low-Resource Setting in Upper Egypt: Service Integration, Psychosocial Burden, Dietary Practices, and the Geo-Spatial Disease Map

Assiut University

TrialNOT YET RECRUITING
Nov 2025Wilson's Disease Treated With D-Penicillamine: Characterization of Skin Damage Secondary to Treatment by Measuring Skin Elasticity

Centre Hospitalier Universitaire de Saint Etienne — NA

TrialRECRUITING
Oct 2025Phase I/II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of GC310 Injection in Patients With Wilson's Disease (WD)

GeneCradle Inc — PHASE1, PHASE2

TrialNOT YET RECRUITING
Jul 2025Gene Therapy for Wilson Disease Evaluated by 64Cu PET/CT

Thomas Damgaard Sandahl

TrialENROLLING BY INVITATION

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

7 programs

FINANCIAL LANDSCAPE SUMMARY

7

Total programs

6

Open now

3

Foundation grants

1

Copay cards

2

Travel grants

Foundation Grants3

PAN Foundation — Wilson disease

PAN Foundation

OpenContact for detailsApply ↗

NORD Patient Assistance — Wilson disease

NORD Patient Assistance

OpenContact for detailsApply ↗

The Assistance Fund — Wilson disease

The Assistance Fund

OpenContact for detailsApply ↗

Copay Assistance1

Penicillamine

Bausch Health

OpenContact for detailsApply ↗

Patient Assistance Programs1

Galzin

Eton Pharmaceuticals

OpenContact for detailsApply ↗

Travel Grants2

RELIVE Organization Medication Assistance

RELIVE Organization

Contact for detailsApply ↗

Wilson Disease Association Patient Assistance Program

Wilson Disease Association

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

2 FDA-approved

Galzin

(Zinc acetate)Orphan drug

Eton Pharmaceuticals, Inc

Approved Jan 1997FDA label ↗

Penicillamine

(PENICILLAMINE)Orphan drugstandard

Endo USA, Inc.

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

13 active trials
2N/A
8Unknown
2EARLY_PHASE1
1PHASE1, PHASE2
13Total recruiting
Search clinical trials for Wilson disease

Recent News & Research

1 article
ClinicalTrials.govMar 15, 2026

Wilson Disease Gene Therapy Enters Clinical Trials

First gene therapy trial for Wilson disease began enrolling, aiming to restore ATP7B protein expression.

Read ↗

Browse all Wilson disease news →

Specialist Network

Top 6 by expertise

View all Wilson disease specialists →

Quick Actions